6. Cheng P, et al. S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective
hematopoiesis in myelodysplastic syndromes. Leukemia. 2019;33:2034-2046.
7. Sallman DA, List A. The central role of inflammatory signaling in the pathogenesis
of myelodysplastic syndromes. Blood. 2019;133:1039-1048.
8. Silvin A, et al. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from
Mild COVID-19. Cell. 2020;182:1401-1418.e18.
SCIENTIFIC PROGRAMME
SESSION I
BONE MARROW
RESPONSE TO VIRAL
INFECTIONS
SESSION II
HAEMATOLOGICAL
RESPONSE TO SARS
COV2 INFECTION
SESSION III
DYSERYTHROPOIESIS IN
CLONAL HAEMOPOIESIS
AND MDS
SESSION IV
ERYTHROPOIESIS
CONTROL
SESSION V
ERYTHROPOIESIS
CONTROL : PHASE 2
SESSION VI
IRON METABOLISM
AND ERYTHROPOIESIS
SESSION VII
INHERITED
DYSERYTHROPOIESIS
SESSION VIII
GENE THERAPY/EDITION
SESSION IX – DRUGS
AND INEFFECTIVE
ERYTHROPOIESIS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
FACULTY DISCLOSURES
